Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001649094-24-000084

PRESIDENT AND CFO acquired 19,108 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GUGGENHIME ANDREW PRESIDENT AND CFO 2024-10-25 Option exercise +19,108 $20.93 $399,930 109,491 D
Derivatives
GUGGENHIME ANDREW PRESIDENT AND CFO 2024-10-25 Option exercise · Stock Option (right to buy) −19,108 125,892 D
Loading xslF345X05/wk-form4_1730149905.xml…